Over the past several decades, the approach to the diagnosis and management of patients
with follicular cell‐derived thyroid cancer has evolved based on improved classification of …

Simple Summary Papillary thyroid carcinoma (PTC) represents 80–90% of all differentiated
thyroid carcinomas. PTC has a high rate of gene fusions and mutations, which can influence …

Since Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP)
was introduced as a new thyroid tumour entity, many studies, and meta-analyses on …

Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is a
borderline thyroid tumour formerly known as noninvasive encapsulated follicular variant of …

Simple Summary Thyroid nodules are frequently detected, but the majority of these nodules
are benign. Molecular markers have become useful for diagnosing the minority of thyroid …

Importance Increasing detection of early-stage papillary thyroid neoplasms without
improvements in mortality has prompted development of strategies to prevent or mitigate …

The term non-invasive follicular thyroid neoplasm with papillary-like nuclear features
(NIFTP) was proposed in 2016 and incorporated as a new entity in the World Health …

Introduction Noninvasive follicular thyroid neoplasm with papillary-like features (NIFTP),
represents a distinct class of thyroid neoplasms with very low risk of adverse outcome and a …

Somatic mutations in cancer driver genes can help diagnosis, prognosis and treatment
decisions. Formalin-fixed paraffin-embedded (FFPE) specimen is the main source of DNA …

Simple Summary RAS mutations have been reported in a wide range of thyroid cancer
histological types, from benign to aggressive phenotypes. The presence of RAS mutations in …